Home Stock

Stock Research: Sanofi

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Sanofi

PAR:SAN FR0000120578
98
  • Value
    99
  • Growth
    93
  • Safety
    Safety
    55
  • Combined
    96
  • Sentiment
    87
  • 360° View
    360° View
    98
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sanofi SA is a French healthcare company focused on the research, development, and marketing of therapeutic solutions. It operates in the Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines industries. Sanofi operates globally, with a focus on research and development of therapeutic solutions. In the last fiscal year, the company had a market cap of $118754 million, profits of $32178 million, and revenue of $45849 million, with 84587 employees.

more

ANALYSIS: With an Obermatt 360° View of 98 (better than 98% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Sanofi are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Sanofi. The consolidated Value Rank has an attractive rank of 99, which means that the share price of Sanofi is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 99% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 55. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 87. ...read more

more
Strongest Rank Stock Returns
Weakest Rank Value
Country France
Industry Pharmaceuticals
Size Large
Website sanofi.com
Index
EURO STOXX 50
CAC 40
CAC All
SBF 120
NASDAQ
Sanofi stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
99 98 99 96
Growth
93 60 51 61
Safety
Safety
55 76 56 27
Sentiment
87 92 44 40
360° View
360° View
98 98 82 60
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
34 76 45 55
Opinions Change
68 49 47 26
Pro Holdings
n/a 94 86 84
Market Pulse
81 50 19 23
Sentiment
87 92 44 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
99 98 99 96
Growth
93 60 51 61
Safety Safety
55 76 56 27
Combined
96 95 90 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
82 50 61 71
Price vs. Earnings (P/E)
69 86 86 87
Price vs. Book (P/B)
89 79 88 78
Dividend Yield
99 94 92 92
Value
99 98 99 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
62 61 39 43
Profit Growth
92 50 46 45
Capital Growth
81 55 67 66
Stock Returns
27 77 48 66
Growth
93 60 51 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
46 68 56 47
Refinancing
48 42 43 6
Liquidity
65 73 63 61
Safety Safety
55 76 56 27

Similar Stocks

Discover high‑ranked alternatives to Sanofi and broaden your portfolio horizons.

ENGIE

PAR:ENGI
Country: France
Industry: Multi-Utilities
Size: Large
Full Stock Analysis

Manitou BF

PAR:MTU
Country: France
Industry: Heavy Machinery
Size: Medium
Full Stock Analysis

Rubis

PAR:RUI
Country: France
Industry: Gas Utilities
Size: Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews